XML 63 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Long-Term Investments (Details) - Schedule of balance sheet - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
BioFirst [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets $ 1,958,500 $ 1,543,152  
Non-current Assets 801,410 739,472 $ 959,454
Current Liabilities 1,675,194 2,663,051 2,909,703
Non-current Liabilities 357,150 103,447 32,522
Stockholders’ Equity (Deficit) 727,566 (483,874)  
Rgene [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets 54,987 68,302  
Non-current Assets 288,160 303,893 374,423
Current Liabilities 2,491,974 2,478,868 1,934,786
Non-current Liabilities 2,048 2,441
Stockholders’ Equity (Deficit) $ (2,150,875) $ (2,109,114)